Antioxidant Role of High-Density Lipoprotein—2nd Edition

A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".

Deadline for manuscript submissions: 30 November 2026 | Viewed by 629

Editor


E-Mail Website
Guest Editor
Cardiovascular Research Group, Faculty of Biology Medicine and Health, University of Manchester, Manchester M13 9PL, UK
Interests: atherosclerosis; diabetes mellitus; dyslipidaemia; insulin resistance; lipids; lipoproteins
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

There is accumulating evidence that high-density lipoprotein (HDL) can protect low-density lipoproteins (LDL) and cell membranes against oxidative modification, which can contribute to numerous disease processes. The most studied disease has been atheroma, but diabetic complications, sepsis, resistance to infection, neoplasms, inflammation and other conditions have all been linked to a loss of protection against oxidation associated with HDL. Although the role of HDL in lipid metabolism is well elucidated, its role as the dominant lipoprotein in tissue fluid—which bathes nearly every cell in the body—is often overlooked. HDL is a repository of numerous proteins and lipids that can potentially protect both tissues and lipoproteins against oxidative damage.

In diabetes, metabolic syndrome, and inflammation, HDL undergoes compositional changes, leading to decreased antioxidant activity. This correlates with its decreased capacity to protect against oxygen free radicals and lactone attack on proteins and phospholipids, posing regulatory and functional consequences.

Our views about HDL have undergone radical revision in recent years: evidence remains largely lacking that it critical for reverse cholesterol transport: most excess cholesterol secreted by the liver is removed before cellular uptake by a process in which HDL is not rate-limiting.

It has been widely reported that dysfunctional HDL—for example, deficient in paraoxonase, apolipoprotein AI, and antioxidant activity—alongside increased serum amyloid A and apolipoprotein AII content may be the true culprit of atheroma pathogenesis and probably other diseases. Serum HDL cholesterol measurement is often an inadequate surrogate for the direct detection of this dysfunctional HDL.

This series of contributions will highlight the mechanisms and components contributing to the antioxidant role of HDL and its disease associations.

Prof. Dr. Paul Durrington
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lipoprotein oxidation
  • cell membrane oxidation
  • HDL antioxidant activity
  • glycosylation
  • atherosclerosis
  • paraoxonase

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

19 pages, 665 KB  
Article
HDL-Associated Specific Paraoxonase-1 Activity Is Linked to Atherogenic Lipoprotein Measures in a High Cardiovascular Risk Population: A Cross-Sectional Study
by Linas Černiauskas, Viktorija Palšytė, Goda Aleknavičiūtė, Eglė Mazgelytė, Inga Bikulčienė, Jolita Badarienė, Egidija Rinkūnienė, Skaistė Arbačiauskaitė, Susann Allelein and Dovilė Karčiauskaitė
Antioxidants 2026, 15(6), 731; https://doi.org/10.3390/antiox15060731 - 9 Jun 2026
Viewed by 333
Abstract
Despite increasing efforts to improve cardiovascular disease (CVD) risk evaluation and management, it remains a leading cause of mortality and morbidity worldwide. This has driven interest in high-density lipoprotein (HDL)-related biomarkers as indicators of oxidative stress and atherogenic processes not fully captured by [...] Read more.
Despite increasing efforts to improve cardiovascular disease (CVD) risk evaluation and management, it remains a leading cause of mortality and morbidity worldwide. This has driven interest in high-density lipoprotein (HDL)-related biomarkers as indicators of oxidative stress and atherogenic processes not fully captured by traditional lipid measurements. In this study, we examined specific paraoxonase 1 (PON1) activity and its relationship with anthropometric, blood pressure, and lipid metabolism measures in 100 middle-aged Lithuanian individuals at high cardiovascular risk. HDL fractions were isolated using iodixanol-based density gradient centrifugation. PON1 concentration and arylesterase activity were measured, and specific activity was defined as arylesterase activity normalized to PON1 concentration. No significant associations were observed between specific PON1 activity and age, body mass index, waist circumference, blood pressure, smoking status, or statin use. Specific PON1 activity was independently associated with lower risk-weighted apolipoprotein B and lower low-density lipoprotein cholesterol levels. These exploratory findings suggest that higher specific PON1 activity may reflect a less atherogenic lipid profile in individuals at high cardiovascular risk, as indicated by its association with LDL-C and with risk-weighted apolipoprotein B. Because direct oxidative stress and inflammatory markers were not measured, interpretations regarding oxidative burden should be considered indirect and hypothesis-generating. Given the cross-sectional nature of the study and the relatively small sample size, these results should be interpreted as exploratory and hypothesis-generating. Further longitudinal studies in larger populations are needed to confirm these observations. Full article
(This article belongs to the Special Issue Antioxidant Role of High-Density Lipoprotein—2nd Edition)
Show Figures

Figure 1

Back to TopTop